These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 35960409)
1. The effect of substance P and its specific antagonist (aprepitant) on the expression of MMP-2, MMP-9, VEGF, and VEGFR in ovarian cancer cells. Momen Razmgah M; Ghahremanloo A; Javid H; AlAlikhan A; Afshari AR; Hashemy SI Mol Biol Rep; 2022 Oct; 49(10):9307-9314. PubMed ID: 35960409 [TBL] [Abstract][Full Text] [Related]
2. Substance P accelerates the progression of human esophageal squamous cell carcinoma via MMP-2, MMP-9, VEGF-A, and VEGFR1 overexpression. Mohammadi F; Javid H; Afshari AR; Mashkani B; Hashemy SI Mol Biol Rep; 2020 Jun; 47(6):4263-4272. PubMed ID: 32436041 [TBL] [Abstract][Full Text] [Related]
3. The substance P/ neurokinin-1 receptor signaling pathway mediates metastasis in human colorectal SW480 cancer cells. Golestaneh M; Firoozrai M; Javid H; Hashemy SI Mol Biol Rep; 2022 Jun; 49(6):4893-4900. PubMed ID: 35429316 [TBL] [Abstract][Full Text] [Related]
4. Potential in vitro therapeutic effects of targeting SP/NK1R system in cervical cancer. Mozafari M; Ebrahimi S; Darban RA; Hashemy SI Mol Biol Rep; 2022 Feb; 49(2):1067-1076. PubMed ID: 34766230 [TBL] [Abstract][Full Text] [Related]
5. The Effect of Blocking Neurokinin-1 Receptor by Aprepitant on the Inflammatory and Apoptosis Pathways in Human Ovarian Cancer Cells. AlAlikhan A; Ghahremanloo A; Javid H; Ebrahimi S; Hashemy SI Cell Biochem Biophys; 2022 Dec; 80(4):819-827. PubMed ID: 36197642 [TBL] [Abstract][Full Text] [Related]
6. SP/NK1R system regulates carcinogenesis in prostate cancer: Shedding light on the antitumoral function of aprepitant. Ebrahimi S; Mirzavi F; Aghaee-Bakhtiari SH; Hashemy SI Biochim Biophys Acta Mol Cell Res; 2022 May; 1869(5):119221. PubMed ID: 35134443 [TBL] [Abstract][Full Text] [Related]
7. The Potential In Vitro Inhibitory Effects of Neurokinin-1 Receptor (NK-1R) Antagonist, Aprepitant, in Osteosarcoma Cell Migration and Metastasis. Alsaeed MA; Ebrahimi S; Alalikhan A; Hashemi SF; Hashemy SI Biomed Res Int; 2022; 2022():8082608. PubMed ID: 36177059 [TBL] [Abstract][Full Text] [Related]
8. The effect of SP/NK1R on expression and activity of glutaredoxin and thioredoxin proteins in prostate cancer cells. Zarei Shandiz S; Assaran Darban R; Javid H; Ghahremanloo A; Hashemy SI Naunyn Schmiedebergs Arch Pharmacol; 2024 Aug; 397(8):5875-5882. PubMed ID: 38334824 [TBL] [Abstract][Full Text] [Related]
9. The SP/NK1R system promotes the proliferation of breast cancer cells through NF-κB-mediated inflammatory responses. Jafarinezhad S; Assaran Darban R; Javid H; Hashemy SI Cell Biochem Biophys; 2023 Dec; 81(4):787-794. PubMed ID: 37740877 [TBL] [Abstract][Full Text] [Related]
10. Investigation of the Role of Neurokinin-1 Receptor Inhibition Using Aprepitant in the Apoptotic Cell Death through PI3K/Akt/NF- Ghahremanloo A; Javid H; Afshari AR; Hashemy SI Biomed Res Int; 2021; 2021():1383878. PubMed ID: 34395609 [TBL] [Abstract][Full Text] [Related]
11. Hepatoblastoma cells express truncated neurokinin-1 receptor and can be growth inhibited by aprepitant in vitro and in vivo. Berger M; Neth O; Ilmer M; Garnier A; Salinas-Martín MV; de Agustín Asencio JC; von Schweinitz D; Kappler R; Muñoz M J Hepatol; 2014 May; 60(5):985-94. PubMed ID: 24412605 [TBL] [Abstract][Full Text] [Related]
12. Aprepitant inhibits the progression of esophageal squamous cancer by blocking the truncated neurokinin‑1 receptor. Zheng Y; Sang M; Liu F; Gu L; Li J; Wu Y; Shan B Oncol Rep; 2023 Jul; 50(1):. PubMed ID: 37203393 [TBL] [Abstract][Full Text] [Related]
13. Antagonism of NK-1R using aprepitant suppresses inflammatory response in rheumatoid arthritis fibroblast-like synoviocytes. Liu X; Zhu Y; Zheng W; Qian T; Wang H; Hou X Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1628-1634. PubMed ID: 31010320 [TBL] [Abstract][Full Text] [Related]
14. The Repurposing of Non-Peptide Neurokinin-1 Receptor Antagonists as Antitumor Drugs: An Urgent Challenge for Aprepitant. Coveñas R; Rodríguez FD; Robinson P; Muñoz M Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958914 [TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor-regulated ovarian cancer invasion and migration involves expression and activation of matrix metalloproteinases. Wang FQ; So J; Reierstad S; Fishman DA Int J Cancer; 2006 Feb; 118(4):879-88. PubMed ID: 16152587 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of MMP-2 and MMP-9 decreases cellular migration, and angiogenesis in in vitro models of retinoblastoma. Webb AH; Gao BT; Goldsmith ZK; Irvine AS; Saleh N; Lee RP; Lendermon JB; Bheemreddy R; Zhang Q; Brennan RC; Johnson D; Steinle JJ; Wilson MW; Morales-Tirado VM BMC Cancer; 2017 Jun; 17(1):434. PubMed ID: 28633655 [TBL] [Abstract][Full Text] [Related]
17. Corneal lymphangiogenesis in dry eye disease is regulated by substance P/neurokinin-1 receptor system through controlling expression of vascular endothelial growth factor receptor 3. Lee SJ; Im ST; Wu J; Cho CS; Jo DH; Chen Y; Dana R; Kim JH; Lee SM Ocul Surf; 2021 Oct; 22():72-79. PubMed ID: 34311077 [TBL] [Abstract][Full Text] [Related]
18. MiR-34b/c-5p and the neurokinin-1 receptor regulate breast cancer cell proliferation and apoptosis. Zhang L; Wang L; Dong D; Wang Z; Ji W; Yu M; Zhang F; Niu R; Zhou Y Cell Prolif; 2019 Jan; 52(1):e12527. PubMed ID: 30334298 [TBL] [Abstract][Full Text] [Related]
19. Metalloelastase in lungs and alveolar macrophages is modulated by extracellular substance P in mice. Xu J; Xu F; Barrett E Am J Physiol Lung Cell Mol Physiol; 2008 Jul; 295(1):L162-70. PubMed ID: 18441096 [TBL] [Abstract][Full Text] [Related]
20. The In Vitro Pro-inflammatory Functions of the SP/NK1R System in Prostate Cancer: a Focus on Nuclear Factor-Kappa B (NF-κB) and Its Pro-inflammatory Target Genes. Ebrahimi S; Erfani B; Alalikhan A; Ghorbani H; Farzadnia M; Afshari AR; Mashkani B; Hashemy SI Appl Biochem Biotechnol; 2023 Dec; 195(12):7796-7807. PubMed ID: 37093533 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]